---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/39335497.md"
description: "$XTALPI(02228.HK)On March 19-20, 2026, the PMO 2026 3rd Metabolism & Weight Loss and Peptide Drugs Summit will focus on the frontiers of metabolic disease and peptide drug R&D, bringing together experts, industry representatives, and technology pioneers from the global biopharmaceutical field to jointly explore innovative breakthroughs and clinical translation practices of peptide drugs in areas such as metabolism and weight loss.On March 19, Dr. Zhang Genwei, Head of the Peptide and Protein Technology Department of XtalPi, is invited by the conference to deliver a keynote speech titled "AI-Driven Next-Generation Cyclic Peptide Drug Discovery" from 11:30-12:00 at [Forum 1: PMO Metabolism & Peptide Drugs] (Forum Venue: Shanghai St. Regis Crown Plaza Hotel, 3rd Floor, Asia-America Hall 2). Based on the cutting edge of AI drug development technology, he will engage in in-depth discussions with industry peers on innovative pathways and core values in peptide drug R&D."
datetime: "2026-03-18T10:23:59.000Z"
locales:
  - [en](https://longbridge.com/en/topics/39335497.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/39335497.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/39335497.md)
author: "[wolf-001](https://longbridge.com/en/profiles/15460724.md)"
---

# $XTALPI(02228.HK)On March 19-20, 2026, the PMO 202…


### Related Stocks

- [02228.HK](https://longbridge.com/en/quote/02228.HK.md)

## Comments (1)

- **lukcy千炫948888 · 2026-03-18T18:09:57.000Z**: This is helpful to me